The Naloxone Market is estimated to witness high growth owing to increasing cases of opioid overdose and drug abuse

Market Overview:

Naloxone is an opiate antagonist used to treat narcotic overdoses. It can reverse the effects of overdose of heroin, oxycodone, hydrocodone, and other narcotics. Naloxone is available in injectable and nasal spray forms.

The global Naloxone Market is estimated to be valued at US$ 1234.6 Mn in 2023 and is expected to exhibit a CAGR of 10. % over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

Nasal naloxone has an ease of administration and is driving the demand for overdose rescue. For instance, in May 2021, Pfizer Inc. launched generic naloxone nasal spray under the brand name Naloxone HCI Nasal Spray for use as an emergency treatment of known or suspected opioid overdose.

Segment Analysis

The Global Naloxone Market Size is segmented into product and distribution channel. Based on product, the naloxone market is segmented into auto-injectors, prefilled syringes and others. The auto-injectors segment dominates the global naloxone market owing to its ease of use and safety features. Auto-injectors eliminate the risk of needle stick injuries and permits quick administration of naloxone in the event of an opioid overdose emergency.

Key Takeaways

The global naloxone market is expected to witness high growth, exhibiting CAGR of 10.% over the forecast period, due to increasing prevalence of opioid overdose cases.

Regional analysis
North America dominates the global naloxone market owing to high prevalence of opioid overdose deaths in the US and Canada. The region is expected to continue its dominance over the forecast period owing to continued efforts by governments to increase access to naloxone products through public health programmes and Good Samaritan laws.

Key players
Key players operating in the naloxone market are Viatris Inc., Opiant Pharmaceuticals, Akorn Operating Company LLC, Pfizer, Inc., Novartis AG, Indivior Plc., Emergent BioSolutions Inc., Amphastar Pharmaceuticals, Inc., Kern Pharma, S.L., Hikma Pharmaceuticals PLC, Mundipharma International Limited, and Kaleo, Inc.

Get More Insights On This Topic: https://www.newsstatix.com/naloxone-market-size-share-analysis-2023-2030/